KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Other Accumulated Expenses (2016 - 2026)

Cme has reported Other Accumulated Expenses over the past 18 years, most recently at $887.1 million for Q1 2026.

  • Quarterly Other Accumulated Expenses rose 41.82% to $887.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $887.1 million through Mar 2026, up 41.82% year-over-year, with the annual reading at $568.8 million for FY2025, 78.03% down from the prior year.
  • Other Accumulated Expenses was $887.1 million for Q1 2026 at Cme, up from $568.8 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $3.1 billion in Q4 2023 and troughed at $454.6 million in Q2 2024.
  • The 5-year median for Other Accumulated Expenses is $625.5 million (2025), against an average of $971.4 million.
  • Biggest five-year swings in Other Accumulated Expenses: tumbled 78.03% in 2025 and later skyrocketed 41.82% in 2026.
  • Tracing CME's Other Accumulated Expenses over 5 years: stood at $2.3 billion in 2022, then soared by 36.2% to $3.1 billion in 2023, then fell by 17.39% to $2.6 billion in 2024, then tumbled by 78.03% to $568.8 million in 2025, then surged by 55.96% to $887.1 million in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $887.1 million, $568.8 million, and $471.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.